TrialThe Lancet. Oncology2012

Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.

Alexander H G Paterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.